Skip to content

Using Ultrasound Sphenopalatine ganglion block Improve Sinus Surgery: A Study on Pain Relief and Better Surgical Visibility.

Bilateral sphenopalatine ganglion block using ultrasound in endoscopic sinus surgery for postoperative pain reduction and surgical field visualization during the surgery: a randomized controlled study - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077416
Enrollment
70
Registered
2024-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J320- Chronic maxillary sinusitis

Interventions

Intervention1: Group a will receive sphenopalatine ganglion block : Group A will receive sphenopalatine ganglion with inj 4ml of 0.5% ropivacaine and 4mg/ml dexamethasone. Control Intervention1

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients between 18 to 65 years of age of either gender ASA I and II scheduled for elective FESS under general anaesthesia

Exclusion criteria

Exclusion criteria: Patients without consent. Patients who are allergic to the study drug. Patient bleeding diathesis. PATIENT with a history of facial trauma. Any systemic or local infection at the site of the needle insertion.

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of ultrasound-guided sphenopalatine ganglion block on post-operative pain for 24 hours and surgical field visualization during surgery in patients undergoing functional endoscopic sinus surgery.Timepoint: 24 hours post operatively

Secondary

MeasureTime frame
To study the hemodynamic response to sphenopalatine ganglion block in FESS surgeryTimepoint: Intraoperatively;• To compare the blood loss with the patients receiving sphenopalatine ganglion block & those who are not receiving block.Timepoint: intraoperatively;• To compare post-operative & intraoperative analgesia consumption among the patients receiving sphenopalatine ganglion block & those not receiving block.Timepoint: 24 hrs post operatively

Countries

India

Contacts

Public ContactMayank Gupta

AIIMS Bathinda

mayankgupta6682@gmail.com8077754166

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026